Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview
Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Bio-Rad Laboratories, Inc. (BIO-B)
Key Financials
Key Financials
Market Cap
9.4B
P/E Ratio
42.53
EPS (TTM)
$-5.68
ROE
0.03%
BIO-B Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Bio-Rad Laboratories, Inc. (NYSE: BIO-B) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bio-Rad Laboratories, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BIO-B on the NYSE shows an RSI of 26.82, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $210.43 for the NYSE listing.
Key metrics behind Bio-Rad Laboratories, Inc.'s NYSE-traded stock include a P/E ratio of 42.53 and a market capitalization of 9.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIO-B on the NYSE.